InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Ferguson Matthew, Chief Financial Officer. Director active across 1 companies, notably Aziyo Biologics, INC.. Aggregated, 3 filings have been published. Total volume traded: €24k. The latest transaction was filed on 8 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
01,288 shares0
Class A Common Stock
SEC:0001415889-22-002860:0·
€11,9281,300 shares@ €9.1756100.0% of flow
Class A Common Stock
SEC:0001104659-21-065258·
Ideal exit: 4 Feb 2022 (T+270)
€11,9281,300 shares@ €9.175650.0% of flow
Class A Common Stock
SEC:0001104659-21-065258:0·
Ideal exit: 4 Feb 2022 (T+270)
3 of 3 declarations
About Ferguson Matthew
Matthew Ferguson is the Chief Financial Officer of AZIYO BIOLOGICS, INC. In this role, he oversees the financial operations and strategy of the company. His experience in the biotechnology sector allows him to provide valuable insights on financial management and compliance. He is committed to supporting the company's growth initiatives.
